Stock & Company Details
Journey Medical Corp $DERM
Price:
N/A
N/A
22M
$213M
52 Week High:
N/A
10 Day Average Volume:
N/A
-19.48
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DERM technical indicators
Latest Journey Medical Corp (DERM) indicator readings as of 2026-08-28.
DERM's 14-day RSI is 60.7, in neutral territory. At $7.47 it is trading 7.4% above its 200-day moving average of $6.96, and above its 50-day average of $6.82. Price sits in the middle of its Bollinger Bands ($5.82 to $7.97). ADX reads 36.5, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Journey Medical Corp is a commercial-stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm, etc.
Finance Bot
Ask your questions
Start by typing a question below.
